Sorry, no content matched your criteria.
Featured Story
Today's $1 Billion Valeant Acquisition (NYSE: VRX) Details and How to Profit
Valeant Pharmaceuticals International Inc. (NYSE: VRX) confirmed its $1 billion acquisition of Sprout Pharmaceuticals Inc. today (Thursday).
Money Morning Defense & Tech Specialist Michael A. Robinson has been following this M&A trend since 2014. He knew the world's top pharmaceutical companies would continue their M&A binge, and he recommended an investment to play that wave.
Robinson's pick has already climbed 13% this year and still has plenty of room to run...
Valeant Pharmaceuticals International Inc. (NYSE: VRX) confirmed its $1 billion acquisition of Sprout Pharmaceuticals Inc. today (Thursday).
Money Morning Defense & Tech Specialist Michael A. Robinson has been following this M&A trend since 2014. He knew the world's top pharmaceutical companies would continue their M&A binge, and he recommended an investment to play that wave.
Robinson's pick has already climbed 13% this year and still has plenty of room to run...